CoChat
Sign Up
Cited by 137Multiple Sclerosis Research StudiesPolyomavirus and related diseasesPeripheral Neuropathies and Disorders

The DOI matches its Crossref record.

Clinical characteristics of patients with late-onset multiple sclerosis

Kis, B., Rumberg, B., Berlit, P.·2008·Journal of Neurology
DOI 10.1007/s00415-008-0778-x
Open this paper in CoChat — free account

Abstract

We evaluated clinical presentation, cerebrospinal fluid (CSF), and magnetic resonance imaging (MRI) in patients with late-onset multiple sclerosis (LOMS). Fifty-two patients with definitive multiple sclerosis (MS) diagnosed after the age of 50 years were identified between 1991 and 2002. Data pertaining to clinical characteristics, CSF analysis, and cerebral and spinal MRI were compared with those of 52 young-onset MS (YOMS) patients matched for sex and disease duration. Mean age at the time of diagnosis was 57 years in the LOMS group - the oldest patient was 82 - and 29 years in the YOMS group. Motor symptoms were significantly more often present in the LOMS than in patients with YOMS (90 % vs. 67 %, p = 0.014). Visual symptoms, residual signs of optic neuritis, and dysarthria were less frequent for LOMS. Sensory symptoms, ataxia, oculomotor symptoms, cognitive disorder, or fatigue did not differ between both groups. The majority of LOMS patients (83 %) had a primary progressive disease course, whereas 94 % of the YOMS group had a relapsing-remitting course. MRI showed typical multifocal supratentorial (LOMS vs. YOMS: 96 % vs. 98 %) and infratentorial (44 % vs. 62 %) lesions without significant group differences. Of particular interest, spinal lesions were more common (81 %) in LOMS compared to YOMS (48 %, p = 0.024), and cerebellar lesions were less frequent in the LOMS group (11 % vs. 44 %, p = 0.001). Gadolinium-enhanced lesions were initially present in less LOMS patient…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00415-008-0778-x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Research works printed but not linked: 37

  1. Cazzullo CL, Ghezzi A, Marforio S, Caputo D (1978) Clinical picture of multiple sclerosis with late onset. Acta Neurol Scand 58:190–196 · DOI
  2. Confavreux C (2002) Infections and the risk of relapse in multiple sclerosis. Brain 125:933–934 · DOI
  3. Confavreux C, Aimard G, Devic M (1980) Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 103:281–300 · DOI
  4. Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126:770–782 · DOI
  5. Cottrell DA, Kremenchutzky M, Rice GP, Koopman WJ, Hader W, Baskerville J, Ebers GC (1999) The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122(Pt 4):625–639 · DOI
  6. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier- Vehier F, Verier A, Pruvo JP, Hache JC, Vermersch P (2002) Devic’s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197:57–61 · DOI
  7. Delalande S, De Seze J, Ferriby D, Stojkovic T, Vermersch P (2002) Late onset multiple sclerosis. Rev Neurol (Paris) 158:1082–1087
  8. Dujmovic I, Mesaros S, Pekmezovic T, Levic Z, Drulovic J (2004) Primary progressive multiple sclerosis: clinical and paraclinical characteristics with application of the new diagnostic criteria. Eur J Neurol 11:439–444 · DOI
  9. Gomez-Garcia AO, Fernandez-Concepcion O, Milan-Ginjauma E (1997) Clinical-epidemiological characteristics of late onset multiple sclerosis. Rev Neurol 25:1863–1866
  10. Hawkins SA, McDonnell GV (1999) Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 67:148–152 · DOI
  11. Hooge JP, Redekop WK (1992) Multiple sclerosis with very late onset. Neurology 42:1907–1910 · DOI
  12. Leibowitz U, Alter M, Halpern L (1964) Clinical studies of multiple sclerosis in Israel. 3. Clinical course and prognosis related to age at onset. Neurology 14:926–932 · DOI
  13. Levic ZM, Dujmovic I, Pekmezovic T, Jarebinski M, Marinkovic J, Stojsavljevic N, Drulovic J (1999) Prognostic factors for survival in multiple sclerosis. Mult Scler (Houndmills, Basingstoke, England) 5:171–178 · DOI
  14. Leyhe T, Laske C, Buchkremer G, Wormstall H, Wiendl H (2005) Dementia as a primary symptom in late onset multiple sclerosis. Case series and review of the literature. Nervenarzt 76:748–755 · DOI
  15. Liguori M, Marrosu MG, Pugliatti M, Giuliani F, De Robertis F, Cocco E, Zimatore GB, Livrea P, Trojano M (2000) Age at onset in multiple sclerosis. Neurol Sci 21:S825–S829 · DOI
  16. Lyon-Caen O, Izquierdo G, Marteau R, Lhermitte F, Castaigne P, Hauw JJ (1985) Late onset multiple sclerosis. A clinical study of 16 pathologically proven cases. Acta Neurol Scand 72:56–60 · DOI
  17. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127 · DOI · Paper page
  18. McDonnell GV, Hawkins SA (1998) An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 50:423–428 · DOI
  19. Moreau T, Confavreux C (2000) Can the prognosis of multiple sclerosis be predicted? Pathologie-biologie 48:132–138
  20. Moreira MA, Felipe E, Mendes MF, Tilbery CP (2000) Multiple sclerosis: descriptive study of its clinical forms in 302 cases. Arq Neuropsiquiatr 58:460–466 · DOI
  21. Myhr KM, Riise T, Vedeler C, Nortvedt MW, Gronning R, Midgard R, Nyland HI (2001) Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Sclers (Houndmills, Basingstoke, England) 7:59–65 · DOI
  22. Noseworthy J, Paty D, Wonnacott T, Feasby T, Ebers G (1983) Multiple sclerosis after age 50. Neurology 33:1537–1544 · DOI
  23. Noseworthy JH (1993) Clinical trials in multiple sclerosis. Curr Opin Neurol Neurosurg 6:209–215
  24. Polliack ML, Barak Y, Achiron A (2001) Late-onset multiple sclerosis. J Am Geriatr Soc 49:168–171 · DOI
  25. Poser S, Raun NE, Poser W (1982) Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand 66:355–362 · DOI
  26. Ramsaransing G, Maurits N, Zwanikken C, De Keyser J (2001) Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler (Houndmills, Basingstoke, England) 7:345–347 · DOI
  27. Runmarker B, Andersson C, Oden A, Andersen O (1994) Prediction of outcome in multiple sclerosis based on multivariate models. J Neurol 241:597–604 · DOI
  28. Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella R, Farina D, Fazio MC, Girlanda P, Le Pira F, Liguori M, Lugaresi A, Nocentini U, Reggio A, Salemi G, Tedeschi G, Trojano M, Valentino P, Quattrone A (2004) Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 251:1208–1214 · DOI
  29. Tartaglino LM, Friedman DP, Flanders AE, Lublin FD, Knobler RL, Liem M (1995) Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195:725–732 · DOI
  30. Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, Polman CH, Stevenson VL, McDonald WI (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831–835 · DOI
  31. Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi MMX, De Sa J (1997) Primary progressive multiple sclerosis. Brain 120(Pt 6):1085–1096 · DOI
  32. Tremlett H, Devonshire V (2006) Is late-onset multiple sclerosis associated with a worse outcome? Neurology 67:954–959 · DOI
  33. Trojano M, Avolio C, Manzari C, Calo A, De Robertis F, Serio G, Livrea P (1995) Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 58:300–306 · DOI
  34. Visscher BR, Liu KS, Clark VA, Detels R, Malmgren RM, Dudley JP (1984) Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol Scand 70:321–328 · DOI
  35. Weinshenker BG (2000) Progressive forms of MS: classification streamlined or consensus overturned? Lancet 355:162–163 · DOI
  36. Weinshenker BG, Sibley WA (1992) Natural history and treatment of multiple sclerosis. Curr Opin Neurol Neurosurg 5:203–211
  37. White AD, Swingler RJ, Compston DA (1990) Features of multiple sclerosis in older patients in South Wales. Gerontology 36:159–164 · DOI

Cited by

Sorted by citations

See all 137

Metadata

Authors
Kis, B., Rumberg, B., & Berlit, P.
Affiliations
Alfried Krupp Hospital (DE)
Corresponding author
Kis, B.
ORCID
Venue
Journal of Neurology
Publisher
Springer Science and Business Media LLC
Published
2008-02-19
Volume
255
Issue
5
Pages
697-702
ISSN
  • 0012-1037 (ISSN-L)
  • 0340-5354
  • 1432-1459
DOI
10.1007/s00415-008-0778-x
OpenAlex
W2082957927
Cited by
137
References
0
Citations by year
2026: 4 · 2025: 15 · 2024: 6 · 2023: 10 · 2022: 7 · 2021: 6 · 2020: 10 · 2019: 5 · 2018: 8 · 2017: 8 · 2016: 8 · 2015: 5 · 2014: 7 · 2013: 6 · 2012: 12
FWCI
4.73
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
  • Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Keywords
late-onset multiple sclerosis, age at diagnosis, primary progressive multiple sclerosis, relapsing-remitting multiple sclerosis, motor symptoms, spinal cord lesions, cerebellar lesions, gadolinium-enhancing lesions, pleocytosis, oligoclonal bands, corticosteroid response, clinical course, cerebrospinal fluid
MeSH terms
Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Brain, Central Nervous System, Diagnostic Errors, Drug Resistance, Evoked Potentials, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Movement Disorders, Multiple Sclerosis, Retrospective Studies, Severity of Illness Index, Spinal Cord, Steroids, Cohort Studies, Age of Onset, Disease Progression, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting, Oligoclonal Bands

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review